COGNITION THERAPEUTICS INC (CGTX)
Cognition Therapeutics, Inc. is a biopharmaceutical company in the clinical stage, focused on identifying and advancing small molecule treatments. The firm's research and development efforts are primarily directed towards age-related neurodegenerative conditions affecting the central nervous system, as well as retinal disorders. Its most advanced experimental therapy is CT1812, which acts as a sigma-2 receptor antagonist. This compound is currently being evaluated in Phase II clinical trials for the management of mild-to-moderate Alzheimer's disease and dementia with Lewy bodies (DLB). Additionally, it has successfully concluded Phase I trials for early-stage Alzheimer's and is undergoing preclinical investigation for dry age-related macular degeneration (AMD). The company's pipeline also includes CT2168, a treatment candidate for synucleinopathies—a category of diseases encompassing DLB and Parkinson's disease—and CT2074, which is in development for dry AMD. Cognition Therapeutics, Inc. was established in 2007 and operates from its headquarters in Purchase, New York.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Cognition Therapeutics, Inc.
NASDAQ:CGTXHealthcare · Biotechnology
-3.32%$0.6949
AH Close$0.6949+0.00%vs close
AH Close$0.6949+0.00%vs close
Mkt Cap$66.08M
Float87.93M
O/S95.09M
Inst Own23.7%
SI8.0%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$23.49M
Total Assets$48.39M
Free Cash Flow-$24.59M
Debt & Equity
Debt 2%
Equity 98%
Total Debt$638K
Total Equity$34.27M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in CGTX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$48.39M
Liabilities$14.12M
Accounts Receivable$9.92M
Accounts Payable$1.12M
Inventory$0
PP&E (Net)$399K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $235K | $0 | $98K | $81K |
| Gross Profit | $0 | $0 | $0 | -$235K | $0 | -$98K | -$81K |
| Gross Margin | - | - | - | - | - | - | - |
| Research and Development | $37.19M | $41.68M | $37.2M | $30.32M | $18.57M | $12.89M | $14.38M |
| Selling, General, and Administrative | $10.61M | $12.29M | $13.53M | $13.23M | $10.03M | $4.52M | $3.45M |
| Other | $0 | $0 | $0 | -$235K | $0 | -$98K | -$13.16M |
| Total Operating Expenses | $47.8M | $53.97M | $50.72M | $43.32M | $28.6M | $17.31M | $4.67M |
| Operating Income (EBIT) | -$47.8M | -$53.97M | -$50.72M | -$43.55M | -$28.6M | -$17.41M | -$17.83M |
| Operating Margin | - | - | - | - | - | - | - |
| Interest Expense | $13K | $25K | $27K | $28K | $893K | $1.75M | $1.02M |
| Interest Income | $0 | $0 | $24.8M | $22.22M | $17.45M | $10.86M | $13.16M |
| Other Income (Expense) | $24.31M | $20M | $24.94M | $22.15M | $16.88M | $9.57M | $0 |
| Income Before Tax (EBT) | -$23.49M | -$33.97M | -$25.79M | -$21.4M | -$11.72M | -$7.84M | -$4.84M |
| Income Tax Expense | $0 | $0 | $0 | -$22.15M | $0 | $0 | $0 |
| Net Income | -$23.49M | -$33.97M | -$25.79M | $757K | -$11.72M | -$10.07M | -$6.95M |
| Net Income Margin | - | - | - | - | - | - | - |
| Supplementary Data | |||||||
| EPS | -0.32 | -0.85 | -0.86 | -0.74 | -0.73 | -0.55 | -0.32 |
| Diluted EPS | -0.32 | -0.85 | -0.86 | -0.74 | -0.73 | -0.55 | -0.32 |
| Weighted Average OS | 72.77M | 39.73M | 29.99M | 28.99M | 22.23M | 21.94M | 21.94M |
| EBITDA | -$23.25M | -$33.68M | -$25.51M | -$21.13M | -$10.73M | -$5.99M | -$3.74M |
| EBITDA Margin | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $36.81M | $25.01M | $29.92M | $41.56M | $54.72M | $5.19M | $2.89M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $36.81M | $25.01M | $29.92M | $41.56M | $54.72M | $5.19M | $2.89M |
| Accounts Receivable | $9.92M | $2.69M | $1.28M | $3.67M | $2.27M | $1.15M | $4.12M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $117K |
| Other Current Assets | $1.26M | $0 | $3.02M | $0 | $11K | $23K | -$88K |
| Total Current Assets | $47.99M | $29.55M | $34.22M | $47.65M | $58.99M | $6.91M | $7.16M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $399K | $679K | $941K | $1.05M | $145K | $211K | $299K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $1.73M | $0 | $0 | $0 |
| Total Long-Term Assets | $399K | $679K | $941K | $2.78M | $145K | $211K | $299K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $48.39M | $30.23M | $35.16M | $50.42M | $59.14M | $7.12M | $7.46M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $1.12M | $1.98M | $3.69M | $3.22M | $4.17M | $2M | $2.36M |
| Short-Term Debt | $307K | $279K | $544K | $634K | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $367K | $1.07M | $1.7M | $1.7M | $753K | $0 | $1.32M |
| Other Current Liabilities | $1.57M | $1.53M | $1.17M | $870K | $2.48M | $985K | -$531K |
| Total Current Liabilities | $13.92M | $11.14M | $10.17M | $7.79M | $7.86M | $3.25M | $3.68M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $12.85M | $6.9M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $1.69M | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | -$695K | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $695K | $0 | $59.2M | $55.3M |
| Total Long-Term Liabilities | $195K | $342K | $520K | $2.38M | $0 | $72.05M | $62.2M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $14.12M | $11.48M | $10.69M | $10.18M | $7.86M | $75.3M | $65.88M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $90K | $60K | $32K | $29K | $22K | $1K | $1K |
| Retained Earnings | -$198.65M | -$175.16M | -$141.19M | -$115.4M | -$94M | -$68.22M | -$58.24M |
| Comprehensive Income & Other | $0 | $0 | -$195K | -$199K | -$198K | -$187K | -$185K |
| Other Stockholders' Equity | $232.83M | $193.85M | $165.63M | $155.62M | $145.25M | $35K | -$184K |
| Total Equity | $34.27M | $18.75M | $24.47M | $40.25M | $51.27M | -$68.18M | -$58.42M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $48.39M | $30.23M | $35.16M | $50.42M | $59.14M | $7.12M | $7.46M |
| Supplementary Data | |||||||
| Total Debt | $638K | $814K | $1.24M | $1.48M | $0 | $12.85M | $6.9M |
| Net Debt | -$36.17M | -$24.2M | -$28.68M | -$40.08M | -$54.72M | $7.66M | $4.01M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$23.49M | -$33.97M | -$25.79M | -$21.4M | -$11.72M | -$7.84M | -$4.84M |
| Depreciation & Amortization | $228K | $266K | $252K | $235K | $93K | $98K | $81K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $238K |
| Stock-Based Compensation | $2.09M | $3.75M | $4.35M | $3.57M | $5.18M | $475K | $361 |
| Changes in Working Capital: | |||||||
| Accounts Receivable | -$7.24M | -$1.41M | $2.39M | -$1.41M | -$1.11M | $3M | -$1.12M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $1.12M |
| Accounts Payable | $3.51M | $0 | $0 | -$1.09M | $2.17M | -$364K | $862K |
| Other Working Capital | $270K | $2.69M | $2.46M | $1.55M | $1.79M | $430K | -$292K |
| Total Working Capital Change | -$3.46M | $1.29M | $4.85M | -$943K | $2.84M | $3.07M | $570K |
| Other Non-Cash Items | $41K | $195K | $318K | $0 | -$33K | $766K | $855K |
| Net Cash from Operating | -$24.59M | -$28.47M | -$16.02M | -$18.53M | -$3.63M | -$3.43M | -$3.1M |
| Investing Activities | |||||||
| Capital Expenditures | $0 | -$4K | -$147K | -$171K | -$27K | -$10K | -$144K |
| Acquisitions | $9K | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $9K | -$4K | -$147K | -$171K | -$27K | -$10K | -$144K |
| Financing Activities | |||||||
| Debt Repaid | $353K | $739K | $811K | $1.4M | $268K | -$5.72M | -$2.83M |
| Common Stock Issuance | $37.09M | $24.35M | $5.33M | $5.32M | $44.22M | $47K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$164K | -$46K | $0 | $1.62M | $9.25M | $0 | -$34K |
| Net Cash from Financing | $36.57M | $23.57M | $4.52M | $5.55M | $53.2M | $5.76M | $2.79M |
| Forex Effect | $0 | $0 | $4K | -$1K | -$11K | -$23K | -$60K |
| Net Change in Cash | $11.99M | -$4.91M | -$11.64M | -$13.16M | $49.53M | $2.3M | -$508K |
| Supplementary Data | |||||||
| Operating Cash Flow | -$24.59M | -$28.47M | -$16.02M | -$18.53M | -$3.63M | -$3.43M | -$3.1M |
| Capital Expenditure | $0 | -$4K | -$147K | -$171K | -$27K | -$10K | -$144K |
| Free Cash Flow | -$24.59M | -$28.48M | -$16.16M | -$18.7M | -$3.66M | -$3.44M | -$3.24M |
| Cash at Beginning | $25.01M | $29.92M | $41.56M | $54.72M | $5.19M | $2.89M | $3.4M |
| Cash at End | $37M | $25.01M | $29.92M | $41.56M | $54.72M | $5.19M | $2.89M |